Catecholamines

Pheochromocytoma can increase blood pressure, and its clinical manifestations can cause persistent hypertension (50%), paroxysmal hypertension (30%), normal blood pressure (10%), etc; accompanied by headache, palpitation and hyperhidrosis, accompanied by abnormal glucose and lipid metabolism, patients can cause serious heart, brain and kidney damage due to long-term hypertension or crisis due to sudden severe hypertension, which is life-threatening; Pheochromocytoma is in a dangerous condition and changes violently. If it is not treated in time, it is easy to cause cardiovascular and cerebrovascular complications and death, and the clinical misdiagnosis rate of pheochromocytoma and paraganglioma is high. Therefore, monitoring catecholamine is of great clinical significance for the early diagnosis of pheochromocytoma and the early screening of secondary hypertension.

Detection Significance

It provides a basis for the diagnosis of hyperthyroidism, hypothyroidism, congestive heart failure, diabetes, renal insufficiency, hypoglycemia and other diseases

To detect the role of catecholamines in plasma for accurate screening, diagnosis, treatment and prognosis of pheochromocytoma, neuroblastoma, hypertension, heart failure, adenomedullary hyperplasia and other diseases.

Applicable People

Endocrine or metabolic disorders
Patients with other cardiovascular complications
Paroxysmal/resistant hypertension
Adrenal incidentaloma
Patients with unstable blood pressure

Family history of pheochromocytoma or management of patients after surgery

Patients with headache, palpitations, and sweating triad

Detection Indicator

7 items

Dopamine, Homovanillin, Norepinephrine, 3-Methoxynorepinephrine, Epinephrine, 3-Methoxynephrine, Vanillylmandelic Acid

Catecholamines

Detection Significance

Applicable People

Detection Indicator

Method Advantage

Sample Type

Blood Collection Volume